| Therapeutic strategies for cardiogenic shock, 2006. | |
| | |
MedLine Citation:
|
PMID: 16401386 Owner: NLM Status: PubMed-not-MEDLINE |
Abstract/OtherAbstract:
|
Cardiogenic shock, a devastating consequence of acute myocardial infarction, is associated with extremely high mortality. Treatment strategies should focus on prompt reperfusion and hemodynamic support. The primary approach for therapy is emergent angiography and revascularization using percutaneous coronary intervention or coronary artery bypass surgery, with the assistance of intra-aortic balloon pump counterpulsation. Several adjunctive pharmacologic agents, particularly inotropic drugs and vasopressors, are also helpful for hemodynamic support. However, these agents have not been shown to provide a survival benefit, and their use is primarily based on clinical experience. Since our last publication, several important advances have been made in the understanding and treatment of cardiogenic shock. Recent evidence suggests that a systemic inflammatory response, including the upregulation of inducible nitric oxide synthase, complement activation, and an inflammatory cytokine cascade, play a role in the development of cardiogenic shock. Newer therapeutic strategies, including C5 inhibitors and nitric oxide synthase inhibitors, are being combined with traditional strategies, such as inotropic agents, vasopressors, and circulatory assist, to treat cardiogenic shock. |
| | |
Authors:
|
Troy C Ellis; Eli Lev; Naji F Yazbek; Neal S Kleiman |
Related Documents
:
|
17646586 - A decade of short-term outcomes in post cardiac surgery ventricular assist device impla... 634186 - Cardiac damage produced by transchest damped sine wave shocks. 15492306 - Prospective randomized multicenter trial of empirical antitachycardia pacing versus sho... 16794796 - Left ventricular assist system through the left ventricle for acute myocardial infarcti... 18158606 - Patient-activated antitachycardia pacing to terminate atrial tachycardias with 1:1 atri... 19804296 - Future of cardiac resynchronization therapy. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Current treatment options in cardiovascular medicine Volume: 8 ISSN: 1092-8464 ISO Abbreviation: Curr Treat Options Cardiovasc Med Publication Date: 2006 Feb |
Date Detail:
|
Created Date: 2006-01-10 Completed Date: 2006-03-01 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9815942 Medline TA: Curr Treat Options Cardiovasc Med Country: United States |
Other Details:
|
Languages: eng Pagination: 79-94 Citation Subset: - |
Affiliation:
|
Department of Cardiology, Methodist Debakey Heart Center, 6565 Fannin, F1090, Houston, TX 77030, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Obesity, diabetes, and associated risk factors.
Next Document: Preparative enzymatic synthesis and HPLC analysis of rhapontigenin: applications to metabolism, phar...